Sanofi-Aventis slashes share earnings forecast for 2006
561701
French pharmaceutical group Sanofi-Aventis has slashed its 2006 earnings per share forecast from 12 percent to just two percent due to competition for its blockbuster blood-thinner Plavix from a generic drug.
103249
Forest Laboratories Inc., which makes antidepressants like Celexa and Lexapro, lowered its profit outlook for 2005 as products from generic drug makers are expected to cut into its sales during the year.
134685
The world's largest automaker lowered its annual earnings forecast Thursday, a few hours after announcing plans to cut about 20 percent of its European workforce by the end of 2006 in hopes of saving about $600 million a year.
443849
Accredo Health lowers earnings guidance for 2005.
150726
GlaxoSmithKline Plc , Europe's  biggest drugmaker, nudged up its 2006 earnings forecast on  Wednesday, but said there were several reasons to be "a little  conservative" about the second half, knocking its shares.
677326
BASEL, Switzerland  - Swiss drugmaker Novartis AG  missed forecasts with a 42 percent drop in fourth-quarter net profit, hit by generic competition and a one-off restructuring charge, sending its shares lower.
102028
Sanofi-Aventis  posted higher than expected fourth-quarter profits on Tuesday and predicted more growth for 2007, but a further delay in its key new anti-obesity drug Acomplia hit the shares.
504955
UnitedHealth Group  on Monday said it has lowered its 2007 revenue forecast after determining its SecureHorizons Medicare Advantage membership will likely decline "modestly" this year.
341742
Shares dropped as the company forecast a decline in 2008 earnings due to generic competition and weaker sales for its diabetes pill.
689528
By Tom Walker, The Atlanta Journal-Constitution  Dec. 7--A top-level shake-up at Yahoo and a disappointing earnings  forecast by Merck & Co. gave investors an excuse Wednesday to sell and take  some profits off the table from the market's recent rally. All the major stock  indexes fell.
357186
SAN FRANCISCO, May 23  â The business software maker CA Inc. predicted fiscal 2008 results below average Wall Street targets, sending its shares down more than 6 percent on Wednesday.
502201
PARIS/LONDON  - Sanofi-Aventis SASY.PA shares   rose on Friday after a U.S. judge blocked further sales of   generic Plavix, but gains were capped as it warned cheap   supplies of the blood-thinner already in the market would hit   2006 profits.
147580
Glaxo expects that the impact of lower sales of its diabetes drug, Avandia, will help cause a drop of about 5 percent in earnings a share in 2008.
254621
UnitedHealth Group  said on Monday it lowered its 2007 revenue forecast after determining its Medicare Advantage membership will likely decline "modestly" this year.
82229
Shares in GlaxoSmithKline fall after it issues a profit warning on the back of falling demand for a key drug.
268630
Shares of Accredo Health Inc. ACDO.O  sank in trade before the opening bell after the provider of  pharmacy and treatment services for patients with chronic  illnesses slashed its fiscal 2005 profit forecast.
243157
Switzerland's Novartis AG will slash 2.5 percent of its global workforce, aiming for annual savings of $1.6 billion in 2010, becoming the latest major drugmaker to undertake a deep restructuring.